Raisio PLC: Financial Statements Bulletin 2022

Raisio / FI. (rg) Finland’s Raisio Group announced its financial results for 12M-2022, the period from January to December. The company is recording sales growth in all market segments. A strong recovery in profitability characterizes fiscal 2022.

January to December 2022 – continuing operations

• The Group’s net sales totalled EUR 220.8 (200.0) million, which signified a growth of 10.4 percent.
• Comparable Ebit was EUR 18.4 (21.3) million, accounting for 8.3 (10.6) percent of net sales. Comparable Ebit decreased by 13.7 percent in relation to the comparison period.
• Ebit was EUR 17.9 (20.2) million, which accounted for 8.1 (10.1) percent of net sales.
• The Healthy Food Segment’s net sales totalled EUR 143.0 (134.3) million. Comparable Ebit was EUR 18.0 (18.4) million, accounting for 12.6 (13.7) percent of net sales. Ebit was EUR 18.0 (18.1) million, which accounted for 12.6 (13.5) percent of net sales.
• The Healthy Ingredients Segment’s net sales totalled EUR 115.7 (96.6) million. Comparable Ebit was EUR 3.4 (6.3) million, accounting for 2.9 (6.6) percent of net sales. Ebit was EUR 3.4 (5.6) million, which accounted for 2.9 (5.8) percent of net sales.
• The Group’s cash flow from continuing operations after financial items and taxes totalled EUR 11.2 (28.4) million.
• The comparable return on investments (ROIC) was 5.6 (8.4) percent and the return on investments (ROIC) was 5.5 (8.0) percent.
• The overall effect of currency conversions was EUR 1.2 (1.4) million on net sales, EUR 0.2 (0.4) million on the comparable Ebit and EUR 0.2 (0.4) million on Ebit.
• The Board of Directors’ dividend proposal for the Annual General Meeting is EUR 0.14 per share, of which EUR 0.08 is the basic dividend in accordance with the company’s dividend policy and EUR 0.06 the supplementary dividend. The company aims to maintain a steady total annual dividend throughout the strategy period, until 2025. However, the annual dividend payments depend on the financial performance of the company and the decisions of the Annual General Meetings for each financial year. The payment of supplementary dividends is in line with our intention, communicated at the beginning of the strategy period, to release additional capital to shareholders.

October to December 2022 – continuing operations

• The Group’s net sales totalled EUR 55.6 (53.8) million, which signified a growth of 3.4 percent.
• Comparable Ebit was EUR 6.0 (4.9) million, accounting for 10.9 (9.2) percent of net sales. Comparable Ebit increased by 22.2 percent in relation to the comparison period.
• Ebit was EUR 5.9 (4.6) million, which accounted for 10.5 (8.6) percent of net sales.
• The Healthy Food Segment’s net sales totalled EUR 35.6 (35.2) million. Comparable Ebit was EUR 4.5 (4.6) million, accounting for 12.7 (13.1) percent of net sales. Ebit was EUR 4.5 (4.5) million, which accounted for 12.7 (12.8) percent of net sales.
• The Healthy Ingredients Segment’s net sales totalled EUR 29.1 (26.7) million. Comparable Ebit was EUR 1.8 (1.6) million, accounting for 6.1 (6.1) percent of net sales. Ebit was EUR 1.8 (1.5) million, which accounted for 6.1 (5.5) percent of net sales.
• The Group’s cash flow from continuing operations after financial items and taxes totalled EUR 10.8 (9.2) million.
• The overall effect of currency conversions was EUR 0.0 (0.9) million on net sales, EUR 0.0 (0.2) million on the comparable Ebit and EUR 0.0 (0.2) million on Ebit.

For additional information please read the Company’s PDF file below (280 KB):

20230208-RAISIO-FY2022.